Go to
JCI Insight
Citations to this article
Arturo Casadevall, … , Michael J. Joyner, Liise-anne Pirofski
Published July 7, 2020
Citation Information: J Clin Invest. 2020;130(10):5112-5114. https://doi.org/10.1172/JCI139760.
Citation Information: J Clin Invest. 2020;130(10):5112-5114. https://doi.org/10.1172/JCI139760.
Abstract
Most patients with COVID-19 lack antibody to SARS-CoV-2 in the first 10 days of illness while the virus drives disease pathogenesis. SARS-CoV-2 antibody deficiency in the setting of a tissue viral burden suggests that using an antibody as a therapeutic agent would augment the antiviral immune response. In this issue of the JCI, Wang and collaborators describe the kinetics of viral load and the antibody responses of 23 individuals with COVID-19 experiencing mild and severe disease. The researchers found that (a) individuals with mild and severe disease produced neutralizing IgG to SARS-CoV-2 10 days after disease onset, (b) SARS-CoV-2 persisted longer in those with severe disease, and (c) there was cross-reactivity between antibodies to SARS-CoV-1 and SARS-CoV-2, but only antibodies from patients with COVID-19 neutralized SARS-CoV-2. These observations provide important information on the serological response to SARS-CoV-2 of hospitalized patients with COVID-19 that can inform the use of convalescent plasma therapy.
Authors
Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski
Citation information
Citations to this article (45)
| Title and authors | Publication | Year |
|---|---|---|
|
COVID-19 convalescent plasma in immunocompromised COVID-19 patients: more certainty and clarity are added to a complex evidence base
Yoon H, Pirofski LA |
eBioMedicine | 2025 |
|
Single MVA-SARS-2-ST/N Vaccination Rapidly Protects K18-hACE2 Mice against a Lethal SARS-CoV-2 Challenge Infection.
Clever S, Limpinsel L, Meyer Zu Natrup C, Schünemann LM, Beythien G, Rosiak M, Hülskötter K, Gregor KM, Tuchel T, Kalodimou G, Freudenstein A, Kumar S, Baumgärtner W, Sutter G, Tscherne A, Volz A |
Viruses | 2024 |
|
Therapeutic equine hyperimmune antibodies with high and broad-spectrum neutralizing activity protect rodents against SARS-CoV-2 infection.
Li E, Han Q, Bi J, Wei S, Wang S, Zhang Y, Liu J, Feng N, Wang T, Wu J, Yang S, Zhao Y, Liu B, Yan F, Xia X |
Frontiers in immunology | 2023 |
|
Potential treatments of COVID-19: Drug repurposing and therapeutic interventions
Raghav PK, Mann Z, Ahluwalia SK, Rajalingam R |
Journal of Pharmacological Sciences | 2023 |
|
Exercise and Experiments of Nature.
Joyner MJ, Wiggins CC, Baker SE, Klassen SA, Senefeld JW |
Comprehensive Physiology | 2023 |
|
Use of Early Donated COVID-19 Convalescent Plasma Is Optimal to Preserve the Integrity of Lymphatic Endothelial Cells
N Amri, R Bégin, N Tessier, L Vachon, L Villeneuve, P Bégin, R Bazin, L Loubaki, C Martel |
Pharmaceuticals (Basel, Switzerland) | 2022 |
|
Increased Antibody Avidity and Cross-Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Variants by Hyperimmunized Transchromosomic Bovine–Derived Human Immunoglobulins for Treatment of Coronavirus Disease 2019
Tang J, Grubbs G, Lee Y, Wu H, Luke TC, Egland KA, Bausch CL, Sullivan EJ, Khurana S |
The Journal of Infectious Diseases | 2022 |
|
Memory B cells and serum immunoglobulins are associated with disease severity and mortality in patients with COVID-19
Çölkesen F, Kepenek Kurt E, Vatansev H, Korkmaz C, Çölkesen F, Yücel F, Yıldız E, Evcen R, Aykan FS, Kılınç M, Aytekin G, Feyzioğlu B, Doğan M, Arslan Ş, Teke T, Keleş S, Reisli İ |
Postgraduate medical journal | 2022 |
|
Advances in Pathogenesis, Progression, Potential Targets and Targeted Therapeutic Strategies in SARS-CoV-2-Induced COVID-19
Zhou H, Ni WJ, Huang W, Wang Z, Cai M, Sun YC |
Frontiers in immunology | 2022 |
|
Equine immunoglobulin fragment F(ab’)2 displays high neutralizing capability against multiple SARS-CoV-2 variants
Gupta D, Ahmed F, Tandel D, Parthasarathy H, Vedagiri D, Sah V, Krishna Mohan B, Khan RA, Kondiparthi C, Savari P, Jain S, Reddy S, Kumar JM, Khan N, Harshan KH |
Clinical Immunology | 2022 |
|
Dysregulation of immunity in COVID-19 and SLE.
Hejazian SS, Hejazian SM, Farnood F, Abedi Azar S |
InflammoPharmacology | 2022 |
|
Early COVID-19 respiratory risk stratification using machine learning.
Douglas MJ, Bell BW, Kinney A, Pungitore SA, Toner BP |
2022 | |
|
Autoimmune and immunoserological markers of COVID-19 pneumonia: Can they help in the assessment of disease severity
Stjepanovic MI, Stojanovic MR, Stankovic S, Cvejic J, Dimic-Janjic S, Popevic S, Buha I, Belic S, Djurdjevic N, Stjepanovic MM, Jovanovic D, Stojkovic-Laloševic M, Soldatovic I, Bonaci-Nikolic B, Miskovic R |
Frontiers in Medicine | 2022 |
|
Challenges in the Detection of SARS-CoV-2: Evolution of the Lateral Flow Immunoassay as a Valuable Tool for Viral Diagnosis
Castrejón-Jiménez NS, García-Pérez BE, Reyes-Rodríguez NE, Vega-Sánchez V, Martínez-Juárez VM, Hernández-González JC |
Biosensors | 2022 |
|
COVID-19 convalescent plasma therapy through the lens of the third year of the pandemic.
|
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022 |
|
The clinical outcomes of high neutralizing antibodies titer convalescent plasma therapy in early developed severe COVID-19 patients; a case-control study.
Nontawong N, Siripongboonsitti T, Tawinprai K, Boonpratoom M, Krailassiri N, Boonkhum C, Soonklang K, Poovorawan Y, Mahanonda N |
Annals of clinical microbiology and antimicrobials | 2022 |
|
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
Michele Donato, Steven Park, Melissa Baker, Robert Korngold, Alison Morawski, Xue Geng, Ming Tan, Andrew Ip, Stuart Goldberg, Scott D. Rowley, Kar F Chow, Emily Brown, Joshua Zenreich, Phyllis McKiernan, Kathryn Buttner, Anna Ullrich, Laura Long, Rena Feinman, Andrea Ricourt, Marlo Kemp, Mariefel Vendivil, Hyung C. Suh, Bindu Balani, Cristina Cicogna, Rani Sebti, Abdulla Al-Khan, Steven J. Sperber, Samit Desai, Stacey L. Fanning, Danit Arad, Ronaldo C. Go, Elizabeth Tam, Keith Rose, Sean Sadikot, David S Siegel, Martin Gutierrez, Tatyana Feldman, Andre Goy, Andrew Pecora, Noa Biran, Lori A. Leslie, Alfred Gillio, Sarah Timmapuri, Michele S. Boonstra, Sam Singer, Sukhdeep Kaur, Ernest Richards, David S Perlin |
JCI Insight | 2021 |
|
COVID-19 is a systemic vascular hemopathy: insight for mechanistic and clinical aspects
DM Smadja, SJ Mentzer, M Fontenay, MA Laffan, M Ackermann, J Helms, D Jonigk, R Chocron, GB Pier, N Gendron, S Pons, JL Diehl, C Margadant, C Guerin, EJ Huijbers, A Philippe, N Chapuis, P Nowak-Sliwinska, C Karagiannidis, O Sanchez, P Kümpers, D Skurnik, AM Randi, AW Griffioen |
Angiogenesis | 2021 |
|
Disease Severity and Durability of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Response: A View Through the Lens of the Second Year of the Pandemic
L Pirofski |
Clinical Infectious Diseases | 2021 |
|
Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
JD Herman, C Wang, C Loos, H Yoon, J Rivera, ME Dieterle, D Haslwanter, RK Jangra, RH Bortz, KJ Bar, B Julg, K Chandran, D Lauffenburger, L Pirofski, G Alter |
Nature Communications | 2021 |
|
Characterization of SARS-CoV-2-specific humoral immunity and its potential applications and therapeutic prospects
J Zheng, Y Deng, Z Zhao, B Mao, M Lu, Y Lin, A Huang |
Cellular and Molecular Immunology | 2021 |
|
Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis
HT Peng, SG Rhind, A Beckett |
2021 | |
|
Use of convalescent plasma for COVID-19 in India: A review & practical guidelines
NS Khaire, N Jindal, LN Yaddanapudi, S Sachdev, R Hans, N Sachdeva, MP Singh, A Agarwal, A Mukherjee, G Kumar, RR Sharma, V Suri, GD Puri, P Malhotra |
The Indian journal of medical research | 2021 |
|
Randomized controlled trial of convalescent plasma therapy against standard therapy in patients with severe COVID-19 disease
M AlQahtani, A Abdulrahman, A Almadani, SY Alali, AM Zamrooni, AH Hejab, RM Conroy, P Wasif, S Otoom, SL Atkin, M Abduljalil |
Scientific Reports | 2021 |
|
Rapid and Flexible Platform To Assess Anti-SARS-CoV-2 Antibody Neutralization and Spike Protein-Specific Antivirals
D Stelitano, SP Weisberg, MP Goldklang, Y Zhu, FT Bovier, GF Kalantarov, G Greco, D Decimo, G Franci, M Cennamo, G Portella, M Galdiero, C Mathieu, B Horvat, IN Trakht, A Moscona, MA Whitt, M Porotto, R Dutch |
mSphere | 2021 |
|
The Case for S2: The Potential Benefits of the S2 Subunit of the SARS-CoV-2 Spike Protein as an Immunogen in Fighting the COVID-19 Pandemic
P Shah, GA Canziani, EP Carter, I Chaiken |
Frontiers in immunology | 2021 |
|
Impact of Convalescent Plasma Therapy on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Profile in Coronavirus Disease 2019 (COVID-19) Patients
Tang J, Grubbs G, Lee Y, Golding H, Khurana S |
Clinical Infectious Diseases | 2021 |
|
Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients
Tang J, Ravichandran S, Lee Y, Grubbs G, Coyle EM, Klenow L, Genser H, Golding H, Khurana S |
Nature Communications | 2021 |
|
Longitudinal antibody repertoire in “mild” versus “severe” COVID-19 patients reveals immune markers associated with disease severity and resolution
Ravichandran S, Lee Y, Grubbs G, Coyle EM, Klenow L, Akasaka O, Koga M, Adachi E, Saito M, Nakachi I, Ogura T, Baba R, Ito M, Kiso M, Yasuhara A, Yamada S, Sakai-Tagawa Y, Iwatsuki-Horimoto K, Imai M, Yamayoshi S, Yotsuyanagi H, Kawaoka Y, Khurana S |
Science Advances | 2021 |
|
Rapid immunoassay and clinical evaluation of the SARS‐CoV‐2 antibody assay on the real express‐6 analyzer
Zhang S, Ning Y, Rong Y, Nie Y, Xiong Z, Li R, Jin T, Cai T |
Journal of Medical Virology | 2021 |
|
COVID-19 Repeated Convalescent Plasma Collection: Analysis of 149 Donations from 88 French Military Health Workers
Conan PL, Ficko C, Chueca M, Rolland C, Javaudin O, Bigaillon C, Durand GA, Leparc-Goffart I, Verret C, Aletti M, Dutasta F, Savini H, Bosson JL, Martinaud C |
Transfusion Medicine and Hemotherapy | 2021 |
|
Convalescent Plasma Therapy in the management of COVID-19 patients-The newer dimensions
Mahapatra S, Rattan R, Mohanty CB |
Transfusion Clinique et Biologique | 2021 |
|
Epitope diversity of SARS-CoV-2 hyperimmune intravenous human immunoglobulins and neutralization of variants of concern
Tang J, Lee Y, Ravichandran S, Grubbs G, Huang C, Stauft CB, Wang T, Golding B, Golding H, Khurana S |
iScience | 2021 |
|
Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
Casadevall A, Joyner MJ, Pirofski LA |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021 |
|
The role of IgG Fc receptors in antibody-dependent enhancement
S Bournazos, A Gupta, JV Ravetch |
Nature Reviews Immunology | 2020 |
|
The HMOX1 Pathway as a Promising Target for the Treatment and Prevention of SARS-CoV-2 of 2019 (COVID-19)
N Batra, CD Souza, J Batra, AG Raetz, AM Yu |
International journal of molecular sciences | 2020 |
|
Pharmaco-Immunomodulatory Therapy in COVID-19
JG Rizk, K Kalantar-Zadeh, MR Mehra, CJ Lavie, Y Rizk, DN Forthal |
Drugs | 2020 |
|
COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice
J Zheng, LY Wong, K Li, AK Verma, ME Ortiz, C Wohlford-Lenane, MR Leidinger, CM Knudson, DK Meyerholz, PB McCray, S Perlman |
Nature | 2020 |
|
The Assessment of Convalescent Plasma Efficacy against COVID-19
A Casadevall, BJ Grossman, JP Henderson, MJ Joyner, S Shoham, L Pirofski, N Paneth |
The American Journal of Medicine | 2020 |
|
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T, Malhotra P, Agarwal A, Mukherjee A, Kumar G, Chatterjee P, Bhatnagar T, Malhotra P, Latha B, Bundas S, Kumar V, Dosi R, Khambholja JK, de Souza R, Mesipogu RR, Srivastava S, Dube S, Chaudhary K, Subash S, Anbuselvi S, Rajendran V, Sundararajaperumal A, Balamanikandan P, Maheswari RS, Jayanthi R, Ragunanthanan S, Bhandari S, Singh A, Pal A, Handa A, Rankawat G, Kargirwar K, Regi J, Rathod D, Pathrose E, Bhutaka N, Patel MH, Verma RJ, Malukani K, Patel S, Thakur A, Joshi S, Kulkarni R, Suthar NN, Shah NM, Purohit HM, Shah CK, Patel MN, Shah S, Shah ST, Memon T, Beriwala VR, Jashnani K, Ezzy F, Agrawal S, Bhadade R, Atish M, Madke T, Kavishwar V, Waghmare R, Valvi N, Chander BT, Sekhar AV, Maurya AK, Hemanth K, Nagamani K, Sudha K, Chandra TR, Rao KT, Vyshnavi J, Upadhyay R, Bahadur S, Pathak R, Seth S, Gupta R, Saxena R, Dwivedi P, Malik R, Chourasia D, Lalwani J, Sharma U, Marko J, Suri A, Kumar V, Kaushik R, Kodan P, Acharya BP, Gaur KK, Gupta A, Sachdeva P, Dogra S, Jindal A, John MJ, Dhanju AS, Khetrepal R, Sharma N, Kukar N, Kavita D, Kumar R, Mahajan R, Singh G, Kaur J, Singh RP, Bassi R, Parikh S, Shrivastav O, Shastri J, Desai M, Udupa S, Bafna VA, Barge V, Madane R, Yadav S, Misra S, Bajpayee A, Garg MK, Bohra GK, Nag V, Anne PB, Nadeem M, Singh P, Niwas R, Khaire NS, Sharma R, Singh MP, Sachdeva N, Sachdev S, Hans R, Suri V, Yaddanapudi L, Lakshmi P, Singh N, Bhushan D, Kumar N, Tambe M, Salvi S, Kadgi N, Sangle S, Nakate L, Joshi S, Karyakarte R, Goyanka S, Sharma N, Verma N, Das A, Bahl M, Wadhwa N, Bhat S, Deshmukh S, Wagh V, Kulkarni A, Yardi T, Kalgud RS, Reddy P, Yevoor K, Gajula P, Maleyur V, Medini S, Mohith H, Gurtoo A, Sud R, Pahuja S, Prakash A, Gogoi P, Shukla S, Reddy DH, Chandra T, Pandey S, Maurya P, Ali W, Kumar V, Upadhyay K, Bhatnagar N, Shah N, Shah M, Patel T, Jaiswal RM, Jain A, Sharma S, Rijhwani P, Gupta N, Patel TC, Solu MG, Patel J, Shah YR, Jarag M, Godbole V, Shah M, Raj R, Nagori I, Jha PR, Shah AD, Yeeli G, Jain A, Gill RK, Babu KS, Babu BS, Mohan A, Vengamma B, Sekhar KC, Damam S, Narsimhulu K, Aparna C, Baleswari G, Reddy KR, Chandrasekhar P, Panjwani SJ, Shah PH, Barvaliya M, Desai K, Akholkar PJ, Baldi M, Yadav A, Gupta M, Rawat N, Chawda D, Natarajan M, Sintha M, Kumar DP, Rabbani F, Khadke VK, Patki D, Marathe S, D\u2019Souza C, Tadha V, Arora S, Gupta DK, Dua S, Chauhan N, Chahar AS, Mammen JJ, Kumar S, Daniel D, Singh R, Dhat V, Agarwal Y, Arora S, Pathak A, Purohit M, Sharma A, Sharma J, Madkaikar M, Joshi K, Yadav RM, Bhagwat S, Karnik ND, Gokhale YA, Naik L, Margam S, Das S, Turuk A, Kumar VS, Kanagasabai K, Sabarinathan R, Deshpande G, Sharma S, Gunjikar R, Shete A, Phagiwala D, Patil C, Shingade S, Jarande K, Kaushal H, Yadav P, Sapkal G, Abraham P |
2020 | |
|
Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic World
Augustine R, Das S, Hasan A, S A, Abdul Salam S, Augustine P, Dalvi YB, Varghese R, Primavera R, Yassine HM, Thakor AS, Kevadiya BD |
Journal of Clinical Medicine | 2020 |
|
Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques
McMahan K, Yu J, Mercado NB, Loos C, Tostanoski LH, Chandrashekar A, Liu J, Peter L, Atyeo C, Zhu A, Bondzie EA, Dagotto G, Gebre MS, Jacob-Dolan C, Li Z, Nampanya F, Patel S, Pessaint L, Van Ry A, Blade K, Yalley-Ogunro J, Cabus M, Brown R, Cook A, Teow E, Andersen H, Lewis MG, Lauffenburger DA, Alter G, Barouch DH |
Nature | 2020 |
|
Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma
Maor Y, Cohen D, Paran N, Israely T, Ezra V, Axelrod O, Shinar E, Izak M, Rahav G, Rahimi-Levene N, Bazofin BM, Gelman R, Dicker D, Brosh-Nissimov T, Megged O, Dahan D, Benov A, Paz A, Edward K, Moran A, Rogowski O, Sorkine P, Mayo A, Zimhony O, Chen J |
2020 | |
|
Optimization of hydroxychloroquine dosing scheme based on COVID-19 patients' characteristics: a review of the literature and simulations.
Karatza E, Ismailos G, Marangos M, Karalis V |
Xenobiotica; the fate of foreign compounds in biological systems | 2020 |
|
Evidence lags behind excitement over blood plasma as a coronavirus treatment.
Ledford H |
Nature | 2020 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)